Innovation in Obesity Pathways - Market Engagement Opportunity

  • NHS SURREY HEARTLANDS INTEGRATED CARE BOARD

F14: Notice for changes or additional information

Notice identifier: 2026/S 000-002877

Procurement identifier (OCID): ocds-h6vhtk-059e57

Published 13 January 2026, 5:51pm



Section one: Contracting authority/entity

one.1) Name and addresses

NHS SURREY HEARTLANDS INTEGRATED CARE BOARD

Dukes Court, Duke Street

Woking

GU215BH

Contact

Robert Kitt

Email

robert.kitt1@nhs.net

Country

United Kingdom

Region code

UKJ2 - Surrey, East and West Sussex

NHS Organisation Data Service

QXU

Internet address(es)

Main address

www.surreyheartlands.org/


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Innovation in Obesity Pathways - Market Engagement Opportunity

two.1.2) Main CPV code

  • 85100000 - Health services

two.1.3) Type of contract

Services

two.1.4) Short description

NHS Surrey Heartlands and NHS Sussex ICBs are preparing to bid for grant funding under the Obesity Pathway Innovation Programme (OPIP): Strand 3-Combined Access and Management for Healthy Ageing and Tackling Obesity, a national innovation competition jointly funded by the Department for Science, Innovation and Technology (DSIT) and Eli Lilly and Company Limited, with up to £85 million available across the UK.

To inform our competition response, we are launching a joint market engagement exercise to explore innovative ideas, technologies, and service models that could inform our competition entries and shape future service opportunities in obesity prevention and management in our ICBs.


Section six. Complementary information

six.6) Original notice reference

Notice number: 2025/S 000-058212


Section seven. Changes

seven.1) Information to be changed or added

seven.2) Other additional information

UPDATE: Innovation in Obesity Pathways - Weight Management and Obesity Service Procurement - Surrey Heartlands ICB

Surrey Heartlands Integrated Care Board (ICB) wishes to update the market on our recent engagement regarding innovation in weight management and obesity pathways. As set out in our public information, we prepared a response to the Obesity Pathway Innovation Programme (OPIP)-a national innovation competition jointly funded by the Department for Science, Innovation and Technology (DSIT) and Eli Lilly and Company Limited.

Following the outcome of the funding competition, Surrey Heartlands ICB has been unsuccessful in being awarded OPIP funding. Consequently, we will not be publishing a tender opportunity in relation to this initiative at this time.

We are grateful to organisations that participated in market engagement and shared insights. Should future commissioning opportunities arise in this area, we will ensure updates are shared via Find a Tender.

NHS Surrey Heartlands ICB